CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Managing Director / Whole Time Director CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, we hereby inform that the Trading Window of the Company shall remain closed for all the Designated Persons and their relatives with effect from April 01, 2022 till 48 hours after the financial results of the Company for the quarter ended March 31, 2022 becomes generally available information. CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31.12.2021
Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31.12.2021 CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, January 28, 2022
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. January 28, 2022, have discussed the following matters: 1. Approval of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021 along with the Limited Review Report thereon. 2. Appointment of M/s. Kavita Khatri & Associates as an Secretarial Auditor for the Financial Year 2021-2022. CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2021 Along With The Limited Review Report Thereon And Appoint Secretarial Auditor Of The Company For The Financial Year 2021-2022.
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 ,inter alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2021 along with the Limited Review Report thereon and appoint Secretarial Auditor of the Company for the Financial Year 2021-2022 CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholding for the Period Ended December 31, 2021
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ashok SomaniDesignation :- Managing Director / Whole Time Director CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ended December 31, 2021 issued by Company's Registrar and Share Transfer Agent (RTA), i.e. M/s. Purva Sharegistry (India) Private Limited thereby confirming the compliances under the said regulation. CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, we hereby inform that the Trading Window of the Company shall remain closed for all the Designated Persons and their relatives with effect from January 01, 2022 till 48 hours after the financial results of the Company for the quarter ended December 31, 2021 becomes generally available information. CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Change in Directorate
INTIMATION OF CHANGE IN DIRECTORSHIP AND CHANGE IN COMPOSITION OF COMMITTEES PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS, 2015